FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma

Gut. 2018 Feb;67(2):395-396. doi: 10.1136/gutjnl-2017-314138. Epub 2017 Jun 7.

¹ Division of Minimally Invasive Interventional, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
² Department of Interventional Radiology, Jieyang Affiliated Hospital, Sun Yat-sen University, Jieyang, China.
³ State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
⁴ Department of Minimally Invasive Interventional and Target Treatment, Affiliated Foshan Hospital of Sun Yat-sen University, Foshan, China.
⁵ Department of Interventional Radiology, First People's Hospital, Guangzhou, China.
⁶ Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China.

No abstract available

Keywords: Advanced HCC; FOLFOX; HAIC.

Publication types